Frankfurt - Delayed Quote EUR

AURORA CANNABIS (21P.F)

6.27 -0.01 (-0.08%)
As of 8:54 PM GMT+2. Market Open.
Loading Chart for 21P.F
DELL
  • Previous Close 6.28
  • Open 6.36
  • Bid 6.26 x --
  • Ask 6.30 x --
  • Day's Range 6.27 - 7.00
  • 52 Week Range 0.34 - 10.78
  • Volume 28,085
  • Avg. Volume 22,251
  • Market Cap (intraday) 341.962M
  • Beta (5Y Monthly) 2.93
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jun 12, 2024 - Jun 17, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

www.auroramj.com

1,130

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 21P.F

Performance Overview: 21P.F

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

21P.F
40.80%
S&P/TSX Composite index
4.87%

1-Year Return

21P.F
19.07%
S&P/TSX Composite index
7.53%

3-Year Return

21P.F
90.93%
S&P/TSX Composite index
15.06%

5-Year Return

21P.F
99.35%
S&P/TSX Composite index
32.60%

Compare To: 21P.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 21P.F

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    340.58M

  • Enterprise Value

    309.76M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.19

  • Price/Book (mrq)

    0.97

  • Enterprise Value/Revenue

    1.46

  • Enterprise Value/EBITDA

    -0.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    151.71%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    275.88M

  • Net Income Avi to Common (ttm)

    410.72M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    148.55M

  • Total Debt/Equity (mrq)

    18.51%

  • Levered Free Cash Flow (ttm)

    --

Company Insights: 21P.F

People Also Watch